These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nephrogenic systemic fibrosis in a gadolinium-naïve patient: successful treatment with oral sirolimus. Ross C; De Rosa N; Marshman G; Astill D Australas J Dermatol; 2015 Aug; 56(3):e59-62. PubMed ID: 25330850 [TBL] [Abstract][Full Text] [Related]
8. Which laboratory parameters are characteristic for nephrogenic systemic fibrosis? Boehm I Nephrol Dial Transplant; 2009 Jul; 24(7):2293; author reply 2293-4. PubMed ID: 19357110 [No Abstract] [Full Text] [Related]
9. [Nephrogenic fibrosing dermatosis: From clinic to microscopy]. Yoldez H; Ahlem B; Abderrahim E; Faten Z; Soumaya R Nephrol Ther; 2018 Feb; 14(1):47-49. PubMed ID: 29239786 [TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis in the podiatric patient. Freed L; Hill J; Gooch D J Am Podiatr Med Assoc; 2012; 102(5):419-21. PubMed ID: 23001737 [TBL] [Abstract][Full Text] [Related]
14. Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis. Kreuter A; Gambichler T; Weiner SM; Schieren G Arch Dermatol; 2008 Nov; 144(11):1527-9. PubMed ID: 19015438 [No Abstract] [Full Text] [Related]
15. Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause. Provenzale JM AJR Am J Roentgenol; 2008 Dec; 191(6):1867-9. PubMed ID: 19020262 [No Abstract] [Full Text] [Related]
16. Nephrogenic Systemic Fibrosis. Sarwal A; Gnanasekaran I Am J Med Sci; 2021 Jan; 361(1):e5-e6. PubMed ID: 32709396 [No Abstract] [Full Text] [Related]
17. Implications of NSF-active and NSF-inert in nephrogenic systemic fibrosis. Wiginton CD AJR Am J Roentgenol; 2008 Dec; 191(6):1864-6. PubMed ID: 19020261 [No Abstract] [Full Text] [Related]
18. What is your diagnosis. Nephrogenic systemic fibrosis. Zaleski L; Xia Y; Cho S Cutis; 2011 Jan; 87(1):13, 19-20. PubMed ID: 21323094 [No Abstract] [Full Text] [Related]